Skip to content

Clinical trials

Completed Carcinoma, Renal Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Completed Country / region: United States Clear all

554 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200025
200119
200217
200321
200431
200529
200644
200729
200824
200918
201021
201119
201223
201318
201422
201524
201628
201724
201823
201917
202019
202110
20229
20234
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed554

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)64
Pfizer22
Memorial Sloan Kettering Cancer Center21
M.D. Anderson Cancer Center17
Novartis Pharmaceuticals17
Bristol-Myers Squibb15
Case Comprehensive Cancer Center13
GlaxoSmithKline9
City of Hope Medical Center8
Bayer7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell554
Kidney Neoplasms191
Carcinoma, Non-Small-Cell Lung104
Melanoma103
Breast Neoplasms63
Neoplasms63
Urinary Bladder Neoplasms52
Stomach Neoplasms51
Pancreatic Neoplasms50
Neoplasm Metastasis49

Trials

Showing 1 to 25 of 554. Each trial links to its page on Pharma Observatory.

454 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.